These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24222902)

  • 41. [Massive paracentesis and administration of dextran 70 vs albumin in cirrhotic patients with tense ascites].
    Hernández Pérez RE; Aguilar Ramírez JR; Hernández López JM; Gómez Maganda y Silva TG
    Rev Gastroenterol Mex; 1995; 60(1):22-6. PubMed ID: 7543691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study.
    Fassio E; Terg R; Landeira G; Abecasis R; Salemne M; Podesta A; Rodriguez P; Levi D; Kravetz D
    J Hepatol; 1992 Mar; 14(2-3):310-6. PubMed ID: 1380024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Albumin substitution : A review of the indications in general internal medicine].
    Dumas D; Benmachiche M; Gachoud D
    Rev Med Suisse; 2021 Nov; 17(760):2022-2026. PubMed ID: 34817939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
    Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé JD; Valla D; Lebrec D
    Gut; 2002 Jan; 50(1):90-4. PubMed ID: 11772973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low dose albumin for the prevention of renal impairment following large volume paracentesis in cirrhosis.
    Hussain W; Khalid AB; Usmani T; Ghufran A; Shah H
    Pak J Med Sci; 2015; 31(3):592-6. PubMed ID: 26150850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
    Chesta J; Brahm J; Latorre R; Gidi J; Hurtado C; Antezana C; Novoa X; Velasco M
    Rev Med Chil; 1990 Aug; 118(8):874-80. PubMed ID: 2152231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathophysiological basis of albumin use in cirrhosis.
    Arroyo V; Fernandez J
    Ann Hepatol; 2011 May; 10 Suppl 1():S6-14. PubMed ID: 21566249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial.
    Narahara Y; Kanazawa H; Fukuda T; Matsushita Y; Harimoto H; Kidokoro H; Katakura T; Atsukawa M; Taki Y; Kimura Y; Nakatsuka K; Sakamoto C
    J Gastroenterol; 2011 Jan; 46(1):78-85. PubMed ID: 20632194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comment to "Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses".
    Pariente A
    Dig Liver Dis; 2012 Jun; 44(6):535. PubMed ID: 22387284
    [No Abstract]   [Full Text] [Related]  

  • 53. Paracentesis in the management of cirrhotic ascites.
    Ginès P; Arroyo V
    J Hepatol; 1993; 17 Suppl 2():S14-8. PubMed ID: 8491965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results?
    Wong CL; Holroyd-Leduc J; Thorpe KE; Straus SE
    JAMA; 2008 Mar; 299(10):1166-78. PubMed ID: 18334692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [When should we give albumin in patients with cirrhosis?].
    Bochatay L; Elkrief L; Spahr L
    Rev Med Suisse; 2015 Sep; 11(484):1596, 1598-601. PubMed ID: 26502620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis.
    Saló J; Ginès A; Ginès P; Piera C; Jiménez W; Guevara M; Fernández-Esparrach G; Sort P; Bataller R; Arroyo V; Rodés J
    J Hepatol; 1997 Oct; 27(4):645-53. PubMed ID: 9365040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites.
    Umgelter A; Reindl W; Franzen M; Lenhardt C; Huber W; Schmid RM
    Intensive Care Med; 2009 Jan; 35(1):152-6. PubMed ID: 18802688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative?
    Burroughs AK
    Dig Liver Dis; 2003 Sep; 35(9):664-7. PubMed ID: 14563191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.